Imetit: Difference between revisions
CSV import |
No edit summary |
||
| Line 22: | Line 22: | ||
[[Category:Research chemicals]] | [[Category:Research chemicals]] | ||
{{stub}} | {{stub}} | ||
== Imetit == | == Imetit == | ||
<gallery> | <gallery> | ||
File:Imetit.svg|Imetit | File:Imetit.svg|Imetit | ||
</gallery> | </gallery> | ||
Latest revision as of 00:02, 17 March 2025
Imetit is a histamine H3 receptor antagonist. It is used in scientific research and has no current medical use.
Chemistry[edit]
Imetit is a potent and selective histamine H3 receptor agonist. It is structurally related to histamine but has been modified to be orally active and to pass the blood-brain barrier.
Pharmacology[edit]
Imetit has been shown to increase wakefulness and improve memory and learning in animal studies. It has also been shown to reduce the release of acetylcholine in the brain, which may have implications for the treatment of Alzheimer's disease.
Research[edit]
Research into the potential therapeutic uses of Imetit is ongoing. It has been suggested that it may have potential in the treatment of obesity, sleep disorders, Alzheimer's disease, and schizophrenia. However, these potential uses are still in the early stages of research and have not been confirmed in clinical trials.
See also[edit]
References[edit]
<references/>
